Director, Market Access and Reimbursement (New Medical Sensors)
AbbottSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Medical Devices, Healthcare Technology, Health Insurance & Payer RelationsIndustries
Requirements
Candidates should possess a Bachelor’s degree, and an advanced degree (MBA, MPH, or related) is strongly preferred. They must have at least 10 years of experience in healthcare reimbursement, with demonstrated success in leading both payer engagement and field-facing access teams. Exceptional communication skills, deep knowledge of U.S. healthcare reimbursement, including commercial payers, CMS, coding and coverage pathways, and health policy trends, are required, along with the ability to develop, negotiate, and maintain relationships with payers and health plans.
Responsibilities
The Director, Field Reimbursement & East Payer Relations will lead and develop the national Field Reimbursement team, ensuring effective provider support for access, coding, billing, and reimbursement of HeartFlow’s products. They will define KPIs and dashboards, develop educational materials, provide strategic leadership and talent development, and anticipate market trends. Furthermore, this role involves leading engagement with named payers in the east geography, fostering payer partnerships, serving as an external leader with payers, health systems, and policy stakeholders, and driving favorable coverage and reimbursement policies for HeartFlow’s products.
Skills
Healthcare reimbursement
Payer engagement
Strategic planning
Operational leadership
Field support
Commercial payer relations
HeartFlow
Non-invasive cardiac testing for heart disease
About HeartFlow
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.
Key Metrics
Redwood City, CaliforniaHeadquarters
2010Year Founded
$858.5MTotal Funding
SERIES_FCompany Stage
HealthcareIndustries
501-1,000Employees